Severe eosinophilic is effectively treated with benralizumab, with especially good outcomes in patients with high BEC and high FeNO.

Asthma is one of the major growth areas in therapeutics and many new drugs are currently in development. These drugs include improvements of existing classes of drugs, notably once-daily inhaled ...

People who have symptoms of both asthma and chronic obstructive pulmonary ... of airflow bronchial and systemic inflammation from eosinophils, a type of white blood cell Your doctor will perform ...

the drug could also face strong competition from AstraZeneca’s AZN Fasenra, also an IL-5 inhibitor. This AZN drug is currently approved for two indications, namely eosinophilic asthma and EGPA.

00001) as well. However, the researchers said, there were no significant differences in cAMP levels between patients with eosinophilic asthma, defined as 300 cells/µL or higher, or neutrophilic ...

There’s a chance people with asthma may have a bad reaction to nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. You can talk with your doctor about other options, including Tylenol.

an Asthma Control Questionnaire score was deemed “best predictor” of 12-month remission in patients with severe eosinophilic asthma, according to study data. “The [5-item Asthma Control ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma infusion ... administering four drugs—Fasenra, Tezspire, Nucala and ...